About Mabwell Company

The company is an innovative biopharmaceutical company with a full industrial chain layout. It always adheres to the vision of “turning innovation from dream to reality”, carries out the mission of “exploring life and benefiting health”. Through innovation at the source, the company provides patients with bioinnovative drugs with better curative efficacy and greater accessibility to meet unmet global clinical needs. The company's main business is R&D, production and sales of innovative drugs and biosimilar drugs. It is supported by efficient innovative research and development and industrialization capabilities, and obtains commercial profits through marketing and sales of therapeutic biological products. The main products are drugs such as antibodies, ADC drugs, recombinant proteins, and small molecule chemicals. Company honors: “Outstanding Case Award” for Shanghai Industrial Talent Team Building Work, “Approved Employer” by the Australian Institute of Accountants, Xingyao List “2021 China Bioinnovative Drug Most Growing Annual Award”, China Pharmaceutical Talent Brand List and the Most Competitive Brand.